Imaging of Alzheimer's and Parkinson's Diseases Flashcards

Describe the commonly used imaging techniques available to assist in the diagnosis of AD and PD Discuss the novel molecular imaging techniques being used in AD, and how these will be useful in patient management and therapeutic interventions Critically evaluate how these imaging techniques will change the classification and diagnosis of AD

1
Q

State some pathological features of AD

A

Extracellular amyloid plaques, intracellular neurofibrillary tangles, neuritic plaques, astrocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where does plaque deposition in AD start?

A

Base of the forebrain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where does neurofibrillary tangle deposition in AD start?

A

Hippocampus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name a PET tracer for AD

A

11C-PIB (N-methyl[C-11]2-[4’-methylamino-phenyl]-6-hydroxyl-benzothiazole); 11F-FDG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does 11C-PIB bind to?

A

Fibrillar amyloid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name a part of the brain where fibrillar amyloid is not deposited in AD

A

Cerebellum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define mild cognitive impairment

A

Impaired memory function for age and education but preserved general cognitive function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What percentage of mild cognitive impairment patients have converted to Alzheimer’s after 3 years?

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does 11C-PIB uptake change as AD progresses?

A

No significant change - suggesting there is no correlation between amyloid load and cognitive performance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does 18F-FDG detect?

A

Glucose metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does 18F-FDG uptake change as AD progresses?

A

Slight decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

State the consensus guidelines for diagnosis of Lewy body dementia

A

Dementia before parkinsonism or within 12 months or parkinsonism and associated with hallucination and confusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the symptoms of Parkinson’s disease dementia

A

Impairment of short-term recall, attention, visuospatial function, and executive function, with personality and behavioural changes, confusion, and hallucinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the pathology associated with Lewy body dementia

A

Cortical Lewy bodies, neurofibrillary tangles, degeneration of subcortical nuclei (substantia nigra, nucleus basalis of Mynert, locus coeruleus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define subjective cognitive impairment

A

Perceived memory problems with normal performance on cognitive testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the stages involved in microglia activation

A

Ramified (R-stage) -> activation signal -> withdrawal (W-stage) -> transitional (T-stage)-> motile (M-stage) -> locomotory (L-stage)

17
Q

Describe the actions of activated microglia

A

Protein expression, proliferation, cytokine secretion, transformation into macrophages

18
Q

Name a PET tracer which binds to activated but not resting microglia

A

PK11195

19
Q

Describe the relationship between microglial activation and AD

A

An increase in microglial activation over time correlates with a decline in cognitive function

20
Q

What happens to CSF tau and amyloid-beta in AD?

A

CSF tau increases, whereas amyloid-beta decreases as it is sequestered in the brain

21
Q

Name a PET tracer for tau

A

T807

22
Q

Describe the relationship between tau load and MMSE performance

A

As tau load increases, MMSE performance decreases